U.K. Cancer Immunotherapy Market to 2032
Overview
The U.K. Cancer Immunotherapy Market is expected to reach a 3.55 USD Billion by 2032 and is projected to grow at a CAGR of 14.90% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.49
Forecast, 2032 (USD Billion)
3.55
CAGR, 2024 - 2032
14.90%
Report Coverage
U.K.
U.K. Cancer Immunotherapy Market 2018-2032 USD Billion
U.K. Cancer Immunotherapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.49 USD Billion
- Projected Market Size (2032): 3.55 USD Billion
- CAGR (2025-2032): 14.90%
Key Findings of U.K. Cancer Immunotherapy Market
- The U.K. Cancer Immunotherapy Market was valued at 1.49 USD Billion in 2024.
- The U.K. Cancer Immunotherapy Market is likely to grow at a CAGR of 14.90% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Intravenous (IV) in Form Segment accounted for the largest share of the market with a revenue of 1.34 USD Billion
- The fastest growing segment Lung Cancer in Application Segment grew Fastest with a CAGR of 20.17% during the forecast period from 2024 to 2032.
U.K. Cancer Immunotherapy Market Scope
U.K. Cancer Immunotherapy Market Segmentation & Scope
Application
- Melanoma
- Multiple Myeloma
- Breast Cancer
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Cervical Cancer
- Stomach Cancer
- Colorectal Cancer
- Head & Neck Cancer
- Others
Product
- Checkpoint Inhibitors
- Monoclonal Antibodies
- Vaccines
- Cell Therapies
- Immunomodulators
- Oncolytic Virus
End User
- Homecare
- Others
- Oncology Clinics
- Hospitals
Form
- Intravenous (IV)
- Intramuscular
- Oral
Distribution Channel
- Direct Tenders
- Retail Sales
- Pharmacies
U.K. Cancer Immunotherapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.49 USD Billion |
| Market Value in 2032 | 3.55 USD Billion |
| CAGR (2025-2032) | 14.90% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Product,End User,Form,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): U.K., leading in terms of revenue 1.49 USD Billion in 2024
- Key Country: U.K., leading in terms of revenue with value of 1,486.06 USD Million in 2024.
Segments and Scope
-
U.K. Cancer Immunotherapy Market to 2032, By Application
- Lung Cancer is the largest segment in U.K. Cancer Immunotherapy Market to 2032 with a revenue of 296.27 USD Billion in the year 2024.
- Lung Cancer is the Fastest growing segment in U.K. Cancer Immunotherapy Market to 2032 with a Growth rate of 20.17 % in forecast period 2025-2032.
-
U.K. Cancer Immunotherapy Market to 2032, By Product
- Checkpoint Inhibitors is the largest segment in U.K. Cancer Immunotherapy Market to 2032 with a revenue of 973.93 USD Billion in the year 2024.
- Checkpoint Inhibitors is the Fastest growing segment in U.K. Cancer Immunotherapy Market to 2032 with a Growth rate of 15.14 % in forecast period 2025-2032.
-
U.K. Cancer Immunotherapy Market to 2032, By End User
- Hospitals is the largest segment in U.K. Cancer Immunotherapy Market to 2032 with a revenue of 998.02 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in U.K. Cancer Immunotherapy Market to 2032 with a Growth rate of 15.09 % in forecast period 2025-2032.
-
U.K. Cancer Immunotherapy Market to 2032, By Form
- Intravenous (IV) is the largest segment in U.K. Cancer Immunotherapy Market to 2032 with a revenue of 1.34 USD Billion in the year 2024.
- Intravenous (IV) is the Fastest growing segment in U.K. Cancer Immunotherapy Market to 2032 with a Growth rate of 15.00 % in forecast period 2025-2032.
-
U.K. Cancer Immunotherapy Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in U.K. Cancer Immunotherapy Market to 2032 with a revenue of 968.66 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in U.K. Cancer Immunotherapy Market to 2032 with a Growth rate of 15.53 % in forecast period 2025-2032.
U.K. Cancer Immunotherapy Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Janssen Pharmaceuticals, Inc. | |||
| Bristol-Myers Squibb Company | |||
| AstraZeneca | |||
| Gilead Sciences, Inc. | |||
U.K. Cancer Immunotherapy Market Geographical Sales Distribution, 2018-2032 USD Billion
U.K. Cancer Immunotherapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.K. Cancer Immunotherapy Market is segmented based on Segmentation Application,Product,End User,Form,Distribution Channel.
U.K. Cancer Immunotherapy Market was valued at USD 1.49(Revenue in USD Billion) in 2021.
U.K. Cancer Immunotherapy Market is projected to grow at a CAGR of 14.90% during the forecast period of 2024 to 2032.
The Intravenous (IV) segment is expected to dominate the U.K. Cancer Immunotherapy Market, holding a largest market share of 1.34 USD Billion in 2024
U.K. Cancer Immunotherapy Market Scope
U.K. Cancer Immunotherapy Market Segmentation & Scope
Application
- Melanoma
- Multiple Myeloma
- Breast Cancer
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Cervical Cancer
- Stomach Cancer
- Colorectal Cancer
- Head & Neck Cancer
- Others
Product
- Checkpoint Inhibitors
- Monoclonal Antibodies
- Vaccines
- Cell Therapies
- Immunomodulators
- Oncolytic Virus
End User
- Homecare
- Others
- Oncology Clinics
- Hospitals
Form
- Intravenous (IV)
- Intramuscular
- Oral
Distribution Channel
- Direct Tenders
- Retail Sales
- Pharmacies
Frequently Asked Questions
The U.K. Cancer Immunotherapy Market is segmented based on Segmentation Application,Product,End User,Form,Distribution Channel.
U.K. Cancer Immunotherapy Market was valued at USD 1.49(Revenue in USD Billion) in 2021.
U.K. Cancer Immunotherapy Market is projected to grow at a CAGR of 14.90% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Cancer Immunotherapy Market for final year is USD 3.55 (USD Billion).
U.K. Cancer Immunotherapy Market Company Profiling
Frequently Asked Questions
The U.K. Cancer Immunotherapy Market is segmented based on Segmentation Application,Product,End User,Form,Distribution Channel.
U.K. Cancer Immunotherapy Market was valued at USD 1.49(Revenue in USD Billion) in 2021.
U.K. Cancer Immunotherapy Market is projected to grow at a CAGR of 14.90% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Cancer Immunotherapy Market for final year is USD 3.55 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.